Skip to main content

Table 6 Correlation of SALL4 and OCT4 expression with patients' survival time

From: Expression of transcript factors SALL4 and OCT4 in a subset of non-small cell lung carcinomas (NSCLC)

Markers Adenocarcinoma Squamous cell carcinomas
(n = 77) (n = 90)
Average survival months(cases) P value Average survival months(cases) P value
SALL4 Negative 35.63 ± 3.18 (n = 51) 0.9866 36.98 ± 4.71 (n = 56) 0.3684
Positive 35.50 ± 6.85 (n = 26) 29.91 ± 6.23 (n = 34)
OCT4 Negative 38.73 ± 4.24 (n = 47) 0.1666 35.75 ± 4.54 (n = 67) 0.4815
Positive 30.38 ± 4.21 (n = 29) 30.13 ± 6.48 (n = 23)